Global Liposomes Drug Delivery Market Research Report 2021

August 2016 | 109 pages | ID: G7334C49053EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Liposomes Drug Delivery

Revenue, means the sales value of Liposomes Drug Delivery

This report studies Liposomes Drug Delivery in Global market, especially in North America, Europe, China, Japan, India and Southeast Asia, focuses on top manufacturers in global market, with sales, price, revenue and market share for each manufacturer, covering

• Enzon
• Gilead Sciences
• Pacira
• Teva Pharmaceutical
• Crucell N.V.
• Chiesi Farmaceutici, S.p.A.
• Novartis
• Janssen Biotech
• Novavax
• Spectrum Pharmaceuticals

Market Segment by Region, this report splits Global into several key Regions, with sales, revenue, market share and growth rate of Liposomes Drug Delivery in these regions, from 2011 to 2021 (forecast), like

• North America
• China
• Europe
• Japan
• India
• Southeast Asia

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Non-interactive sterically stabilized (long- circulating) liposomes(LCL)
• Highly interactive cationic liposomes
• Type III

Split by application, this report focuses on sales, market share and growth rate of Liposomes Drug Delivery in each application, can be divided into

• Ocular Applications
• Pulmonary Applications
• Cancer Therapy

Contents

Global Liposomes Drug Delivery Market Research Report 2021

1 LIPOSOMES DRUG DELIVERY OVERVIEW

1.1 Product Overview and Scope of Liposomes Drug Delivery
1.2 Liposomes Drug Delivery Segment by Types
  1.2.1 Global Sales Market Share of Liposomes Drug Delivery by Type in 2015
  1.2.2 Non-interactive sterically stabilized (long- circulating) liposomes(LCL)
  1.2.3 Highly interactive cationic liposomes
  1.2.4 Type III
1.3 Liposomes Drug Delivery Segment by Applications
  1.3.1 Ocular Applications
  1.3.2 Pulmonary Applications
  1.3.3 Cancer Therapy
1.4 Liposomes Drug Delivery Market by Regions
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 India Status and Prospect (2011-2021)
  1.4.6 Southeast Asia Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Liposomes Drug Delivery (2011-2021)
  1.5.1 Global Liposomes Drug Delivery Sales and Revenue (2011-2021)
  1.5.2 Global Liposomes Drug Delivery Sales and Growth Rate (2011-2021)
  1.5.3 Global Liposomes Drug Delivery Revenue and Growth Rate (2011-2021)

2 GLOBAL LIPOSOMES DRUG DELIVERY MARKET COMPETITION BY MANUFACTURERS

2.1 Global Liposomes Drug Delivery Sales and Share by Manufacturers (2015 and 2016)
2.2 Global Liposomes Drug Delivery Revenue and Share by Manufacturers (2015 and 2016)
2.3 Manufacturers Liposomes Drug Delivery Manufacturing Base Distribution and Product Type
2.4 Competitive Situation and Trends
  2.4.1 Expansions
  2.4.2 New Product Launches
  2.4.3 Acquisitions
  2.4.4 Other Developments

3 GLOBAL LIPOSOMES DRUG DELIVERY ANALYSIS BY REGION

3.1 Global Liposomes Drug Delivery Sales, Revenue and Market Share by Region (2011-2021)
  3.1.1 Global Liposomes Drug Delivery Sales Market Share by Region (2011-2021)
  3.1.2 Global Liposomes Drug Delivery Revenue Market Share by Region (2011-2021)
3.2 North America
  3.2.1 North America Liposomes Drug Delivery Sales, Revenue and Price (2011-2021)
  3.2.2 North America Liposomes Drug Delivery Sales, Revenue and Growth Rate (2011-2021)
3.3 Europe
  3.3.1 Europe Liposomes Drug Delivery Sales, Revenue and Price (2011-2021)
  3.3.2 Europe Liposomes Drug Delivery Sales, Revenue and Growth Rate (2011-2021)
3.4 China
  3.4.1 China Liposomes Drug Delivery Sales, Revenue and Price (2011-2021)
  3.4.2 China Liposomes Drug Delivery Sales, Revenue and Growth Rate (2011-2021)
3.5 Japan
  3.5.1 Japan Liposomes Drug Delivery Sales, Revenue and Price (2011-2021)
  3.5.2 Japan Liposomes Drug Delivery Sales, Revenue and Growth Rate (2011-2021)
3.6 India
  3.6.1 India Liposomes Drug Delivery Sales, Revenue and Price (2011-2021)
  3.6.2 India Liposomes Drug Delivery Sales, Revenue and Growth Rate (2011-2021)
3.7 Southeast Asia
  3.7.1 Southeast Asia Liposomes Drug Delivery Sales, Revenue and Price (2011-2021)
  3.7.2 Southeast Asia Liposomes Drug Delivery Sales, Revenue and Growth Rate (2011-2021)

4 GLOBAL LIPOSOMES DRUG DELIVERY ANALYSIS BY TYPE

4.1 Global Liposomes Drug Delivery Sales, Revenue, Market Share and Growth Rate by Type (2011-2021)
  4.1.1 Global Liposomes Drug Delivery Sales and Market Share by Type (2011-2021)
  4.1.2 Global Liposomes Drug Delivery Revenue, Market Share and Growth Rate by Type (2011-2021)
4.2 Non-interactive sterically stabilized (long- circulating) liposomes(LCL) Sales, Revenue, Price and Growth (2011-2021)
4.3 Highly interactive cationic liposomes Sales, Revenue, Price and Growth (2011-2021)
4.4 Type III Sales, Revenue, Price and Growth (2011-2020)

5 GLOBAL LIPOSOMES DRUG DELIVERY MARKET ANALYSIS BY APPLICATION

5.1 Global Liposomes Drug Delivery Sales and Market Share by Application (2011-2021)
5.2 Major Regions Liposomes Drug Delivery Sales by Application in 2015 and 2016
  5.2.1 North America Liposomes Drug Delivery Sales by Application
  5.2.2 Europe Liposomes Drug Delivery Sales by Application
  5.2.3 China Liposomes Drug Delivery Sales by Application
  5.2.4 Japan Liposomes Drug Delivery Sales by Application
  5.2.5 India Liposomes Drug Delivery Sales by Application
  5.2.6 Southeast Asia Liposomes Drug Delivery Sales by Application

6 GLOBAL LIPOSOMES DRUG DELIVERY MANUFACTURERS ANALYSIS

6.1 Enzon
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Liposomes Drug Delivery Product Overview
    6.1.2.1 Non-interactive sterically stabilized (long- circulating) liposomes(LCL)
    6.1.2.2 Highly interactive cationic liposomes
    6.1.2.3 Type III
  6.1.3 Liposomes Drug Delivery Sales, Revenue, Price of Enzon (2015 and 2016)
6.2 Gilead Sciences
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Liposomes Drug Delivery Product Overview
    6.2.2.1 Non-interactive sterically stabilized (long- circulating) liposomes(LCL)
    6.2.2.2 Highly interactive cationic liposomes
    6.2.2.3 Type III
  6.2.3 Liposomes Drug Delivery Sales, Revenue, Price of Gilead Sciences (2015 and 2016)
6.3 Pacira
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Liposomes Drug Delivery Product Overview
    6.3.2.1 Non-interactive sterically stabilized (long- circulating) liposomes(LCL)
    6.3.2.2 Highly interactive cationic liposomes
    6.3.2.3 Type III
  6.3.3 Liposomes Drug Delivery Sales, Revenue, Price of Pacira (2015 and 2016)
6.4 Teva Pharmaceutical
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Liposomes Drug Delivery Product Overview
    6.4.2.1 Non-interactive sterically stabilized (long- circulating) liposomes(LCL)
    6.4.2.2 Highly interactive cationic liposomes
  6.4.3 Liposomes Drug Delivery Sales, Revenue, Price of Teva Pharmaceutical (2015 and 2016)
6.5 Crucell N.V.
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Liposomes Drug Delivery Product Overview
    6.5.2.1 Non-interactive sterically stabilized (long- circulating) liposomes(LCL)
    6.5.2.2 Highly interactive cationic liposomes
  6.5.3 Liposomes Drug Delivery Sales, Revenue, Price of Crucell N.V. (2015 and 2016)
6.6 Chiesi Farmaceutici, S.p.A.
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Liposomes Drug Delivery Product Overview
    6.6.2.1 Non-interactive sterically stabilized (long- circulating) liposomes(LCL)
    6.6.2.2 Highly interactive cationic liposomes
  6.6.3 Liposomes Drug Delivery Sales, Revenue, Price of Chiesi Farmaceutici, S.p.A. (2015 and 2016)
6.7 Novartis
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Liposomes Drug Delivery Product Overview
    6.7.2.1 Non-interactive sterically stabilized (long- circulating) liposomes(LCL)
    6.7.2.2 Highly interactive cationic liposomes
  6.7.3 Liposomes Drug Delivery Sales, Revenue, Price of Novartis (2015 and 2016)
6.8 Janssen Biotech
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Liposomes Drug Delivery Product Overview
    6.8.2.1 Non-interactive sterically stabilized (long- circulating) liposomes(LCL)
    6.8.2.2 Highly interactive cationic liposomes
  6.8.3 Liposomes Drug Delivery Sales, Revenue, Price of Janssen Biotech (2015 and 2016)
6.9 Novavax
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Liposomes Drug Delivery Product Overview
    6.9.2.1 Non-interactive sterically stabilized (long- circulating) liposomes(LCL)
    6.9.2.2 Highly interactive cationic liposomes
  6.9.3 Liposomes Drug Delivery Sales, Revenue, Price of Novavax (2015 and 2016)
6.10 Spectrum Pharmaceuticals
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Liposomes Drug Delivery Product Overview
    6.10.2.1 Non-interactive sterically stabilized (long- circulating) liposomes(LCL)
    6.10.2.2 Highly interactive cationic liposomes
  6.10.3 Liposomes Drug Delivery Sales, Revenue, Price of Spectrum Pharmaceuticals (2015 and 2016)

7 INDUSTRY POLICY ANALYSIS

8 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Liposomes Drug Delivery
Figure Global Sales Market Share of Liposomes Drug Delivery by Type in 2015
Table Liposomes Drug Delivery Product Type of by Manufacturers
Table Liposomes Drug Delivery Sales Market Share by Application in 2015 and 2016
Figure North America Liposomes Drug Delivery Revenue and Growth Rate (2011-2021)
Figure China Liposomes Drug Delivery Revenue and Growth Rate (2011-2021)
Figure Europe Liposomes Drug Delivery Revenue and Growth Rate (2011-2021)
Figure Japan Liposomes Drug Delivery Revenue and Growth Rate (2011-2021)
Figure India Liposomes Drug Delivery Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Liposomes Drug Delivery Revenue and Growth Rate (2011-2021)
Table Global Liposomes Drug Delivery Sales and Revenue (2011-2021)
Figure Global Liposomes Drug Delivery Sales and Growth Rate (2011-2021)
Figure Global Liposomes Drug Delivery Revenue and Growth Rate (2011-2021)
Table Global Liposomes Drug Delivery Sales of Key Manufacturers (2015 and 2016)
Table Global Liposomes Drug Delivery Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Liposomes Drug Delivery Sales Share by Manufacturers
Figure 2016 Liposomes Drug Delivery Sales Share by Manufacturers
Table Global Liposomes Drug Delivery Revenue by Manufacturers (2015 and 2016)
Table Global Liposomes Drug Delivery Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Liposomes Drug Delivery Revenue Share by Manufacturers
Table 2016 Global Liposomes Drug Delivery Revenue Share by Manufacturers
Table Manufacturers Liposomes Drug Delivery Manufacturing Base Distribution and Product Type
Table Global Liposomes Drug Delivery Sales Market by Region (2011-2021)
Figure Global Liposomes Drug Delivery Sales Market by Region (2011-2021)
Figure Global Liposomes Drug Delivery Sales Market Share by Region (2011-2021)
Table Global Liposomes Drug Delivery Revenue Market by Region (2011-2021)
Table Global Liposomes Drug Delivery Revenue Market Share by Region (2011-2021)
Table North America Liposomes Drug Delivery Sales, Revenue and Price (2011-2021)
Figure North America Liposomes Drug Delivery Sales, Revenue and Growth Rate (2011-2021)
Table Europe Liposomes Drug Delivery Sales, Revenue and Price (2011-2021)
Figure Europe Liposomes Drug Delivery Sales, Revenue and Growth Rate (2011-2021)
Table China Liposomes Drug Delivery Sales, Revenue and Price (2011-2021)
Figure China Liposomes Drug Delivery Sales, Revenue and Growth Rate (2011-2021)
Table Japan Liposomes Drug Delivery Sales, Revenue and Price (2011-2021)
Figure Japan Liposomes Drug Delivery Sales, Revenue and Growth Rate (2011-2021)
Table India Liposomes Drug Delivery Sales, Revenue and Price (2011-2021)
Figure India Liposomes Drug Delivery Sales, Revenue and Growth Rate (2011-2021)
Table Southeast Asia Liposomes Drug Delivery Sales, Revenue and Price (2011-2021)
Figure Southeast Asia Liposomes Drug Delivery Sales, Revenue and Growth Rate (2011-2021)
Table Global Liposomes Drug Delivery Sales by Type (2011-2021)
Table Global Liposomes Drug Delivery Sales Share by Type (2011-2021)
Figure Sales Market Share of Liposomes Drug Delivery by Type (2011-2021)
Figure Global Liposomes Drug Delivery Sales Growth Rate by Type (2011-2021)
Table Global Liposomes Drug Delivery Revenue by Type (2011-2021)
Table Global Liposomes Drug Delivery Revenue Share by Type (2011-2021)
Figure Global Liposomes Drug Delivery Revenue Growth Rate by Type (2011-2021)
Figure Non-interactive sterically stabilized (long- circulating) liposomes(LCL) Sales, Revenue and Growth (2011-2021)
Figure Non-interactive sterically stabilized (long- circulating) liposomes(LCL) Price Trend (2011-2021)
Figure Highly interactive cationic liposomes Sales, Revenue and Growth (2011-2021)
Figure Highly interactive cationic liposomes Price Trend (2011-2021)
Figure Type III Sales, Revenue and Growth (2011-2021)
Figure Type III Price Trend (2011-2021)
Table Global Liposomes Drug Delivery Sales by Application (2011-2021)
Table Global Liposomes Drug Delivery Sales Market Share by Application (2011-2021)
Figure Global Liposomes Drug Delivery Sales Market Share by Application in 2015
Figure Global Liposomes Drug Delivery Sales Market Share by Application in 2021
Table North America Liposomes Drug Delivery Sales by Application (2015 and 2016)
Table Europe Liposomes Drug Delivery Sales by Application (2015 and 2016)
Table China Liposomes Drug Delivery Sales by Application (2015 and 2016)
Table Japan Liposomes Drug Delivery Sales by Application (2015 and 2016)
Table India Liposomes Drug Delivery Sales by Application (2015 and 2016)
Table Southeast Asia Liposomes Drug Delivery Sales by Application (2015 and 2016)
Table Global Liposomes Drug Delivery Sales Growth Rate by Application (2011-2021)
Figure Global Liposomes Drug Delivery Sales Growth Rate by Application (2011-2021)
Table Enzon Basic Information List
Table Liposomes Drug Delivery Sales, Revenue, Price of Enzon (2015 and 2016)
Table Gilead Sciences Basic Information List
Table Liposomes Drug Delivery Sales, Revenue, Price of Gilead Sciences (2015 and 2016)
Table Pacira Basic Information List
Table Liposomes Drug Delivery Sales, Revenue, Price of Pacira (2015 and 2016)
Table Teva Pharmaceutical Basic Information List
Table Liposomes Drug Delivery Sales, Revenue, Price of Teva Pharmaceutical (2015 and 2016)
Table Crucell N.V. Basic Information List
Table Liposomes Drug Delivery Sales, Revenue, Price of Crucell N.V. (2015 and 2016)
Table Chiesi Farmaceutici, S.p.A. Basic Information List
Table Liposomes Drug Delivery Sales, Revenue, Price of Chiesi Farmaceutici, S.p.A. (2015 and 2016)
Table Novartis Basic Information List
Table Liposomes Drug Delivery Sales, Revenue, Price of Novartis (2015 and 2016)
Table Janssen Biotech Basic Information List
Table Liposomes Drug Delivery Sales, Revenue, Price of Janssen Biotech (2015 and 2016)
Table Novavax Basic Information List
Table Liposomes Drug Delivery Sales, Revenue, Price of Novavax (2015 and 2016)
Table Spectrum Pharmaceuticals Basic Information List
Table Liposomes Drug Delivery Sales, Revenue, Price of Spectrum Pharmaceuticals (2015 and 2016)